Predictors of survival in systemic sclerosis (scleroderma)

Area of Science:

• Rheumatology
• Clinical Epidemiology
• Internal Medicine

Background:

• Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis, vasculopathy, and immune dysregulation.
• Long-term survival in SSc patients varies significantly, influenced by disease severity and organ involvement.
• Predicting prognosis is crucial for patient management and resource allocation.

Purpose of the Study:

• To identify demographic, clinical, and laboratory predictors of survival in patients with systemic sclerosis.
• To analyze the relationship between early disease markers and long-term outcomes in SSc.
• To develop a predictive model for shortened survival in SSc.

Main Methods:

• Follow-up study of 264 patients with definite systemic sclerosis (SSc) enrolled in the Scleroderma Criteria Cooperative Study (SCCS).
• Survival analyses were performed using 484 variables recorded at study entry (within 2 years of diagnosis).
• Statistical methods included survival tree analysis and Cox proportional hazards models.

Main Results:

• Overall survival declined linearly, with cumulative survival rates of <80% at 2 years, 50% at 8.5 years, and 30% at 12 years.
• Early organ involvement (renal, cardiac, pulmonary, gastrointestinal) predicted reduced survival.
• Key predictors of reduced survival included older age (>64 years), elevated blood urea nitrogen (>16 mg/dl), anemia (hemoglobin ≤11 gm/dl), and reduced pulmonary function.

Conclusions:

• Early identification of specific clinical and laboratory variables can predict shortened survival in systemic sclerosis patients.
• Patients with SSc aged ≤64 years and hemoglobin ≤11 gm/dl, or >64 years with BUN >16 mg/dl, face the poorest survival prospects.
• These findings can aid in identifying high-risk SSc patients for closer monitoring and intervention.